On August 6, Zoetis rose 5.65% in pre-market trading, trading at approximately $79.65/share, with turnover of $30.17 million.

On the news front, the company reported Q2 adjusted EPS of $1.87, slightly beating the consensus estimate of $1.86 and representing a 6.25% year-over-year increase. However, revenue of $2.468 billion missed the $2.502 billion estimate, and the company significantly lowered full-year guidance, now expecting adjusted EPS of $6.15-$6.25 versus prior guidance of $6.85-$7.00, with revenue forecast cut to $91.2-$93.2 billion from $96.8-$99.6 billion. Management cited greater pressure in the companion animal market, reduced clinic visits, and heightened pet owner price sensitivity.

Despite the weak guidance, shares rallied as the stock had already plunged over 30% following Q1 results and the initial guidance cut in May, when it dropped more than 20% in a single session. Multiple investment banks had subsequently reduced price targets to the $80-$85 range, indicating substantial pessimism was already priced in. The marginal EPS beat appears to have catalyzed a technical recovery from deeply oversold levels.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)